U.S. markets close in 4 hours 6 minutes
  • S&P 500

    3,815.36
    -16.03 (-0.42%)
     
  • Dow 30

    30,837.63
    -130.19 (-0.42%)
     
  • Nasdaq

    11,271.62
    -50.61 (-0.45%)
     
  • Russell 2000

    1,714.98
    -26.35 (-1.51%)
     
  • Crude Oil

    96.40
    -3.10 (-3.12%)
     
  • Gold

    1,736.10
    -27.80 (-1.58%)
     
  • Silver

    19.08
    -0.05 (-0.24%)
     
  • EUR/USD

    1.0167
    -0.0103 (-1.01%)
     
  • 10-Yr Bond

    2.8890
    +0.0800 (+2.85%)
     
  • GBP/USD

    1.1895
    -0.0057 (-0.48%)
     
  • USD/JPY

    135.6830
    -0.1590 (-0.12%)
     
  • BTC-USD

    20,141.54
    +670.32 (+3.44%)
     
  • CMC Crypto 200

    435.88
    +0.36 (+0.08%)
     
  • FTSE 100

    7,107.77
    +82.30 (+1.17%)
     
  • Nikkei 225

    26,107.65
    -315.82 (-1.20%)
     

Stock rebound uncertain for U.S. biotechs as risks multiply for investors

·4 min read
Stock rebound uncertain for U.S. biotechs as risks multiply for investors
In this article:
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.

U.S. biotechs and other health care stocks accounted for about 11% of all losses in U.S. equity values during the five-month period analyzed by The Business Journals.